Kristen Danielle Whitaker

Kristen Whitaker practices at MedStar Washington Hospital Center in Washington, District of Columbia, part of MedStar Health.

Kristen Whitaker's NPI, 1902162241, was assigned on April 11, 2012. Kristen Whitaker graduated from Drexel University College of Medicine in 2012. Kristen Whitaker holds Pennsylvania license MD465240.

Kristen Whitaker's primary practice is MedStar Washington Hospital Center, at 110 Irving Street NW, Washington, DC 20010 in The District County. The practice phone is (202) 877-7000.

Kristen Whitaker's primary practice is MedStar Washington Hospital Center in Washington, District of Columbia, part of MedStar Health. The medical group on file is MedStar Medical Group. Dmand AI also links Kristen Whitaker to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Kristen Whitaker practices, 2 sites in all. Vendor and product names are available with a free account.

Medical oncology is Kristen Whitaker's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Kristen Whitaker is licensed in Pennsylvania.

CMS data shows 339 Medicare services from Kristen Whitaker across 6 procedure codes in 2024, for 119 Medicare patients. Medicare paid $33,778 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 119 Medicare patients who saw Kristen Whitaker in 2024. The largest group is 65 to 74, with 44 patients. 75% of them have cancer, and 75% have high blood pressure. 35% are also on Medicaid. Their average risk score is 1.88, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Kristen Whitaker's median patient age at 68, with 95% women.

In 2024, Kristen Whitaker wrote 259 Medicare Part D claims for 70 patients. 91% of them were for generic drugs. CMS names the drug for 219 of them, across 7 drugs with 11 or more claims each, at $245,262 in total drug cost. In 2023, CMS named 66 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Kristen Whitaker for performance year 2024, reported as part of a group. Kristen Whitaker accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 61 general payments to Kristen Whitaker from 19 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 41% of the total. Merck Sharp & Dohme Corporation paid the most, $6,207. It also lists 2 research payments totaling $1,270 in 2021.

Kristen Whitaker graduated from Drexel University College of Medicine in 2012.